MGMT and PTEN as potential prognostic markers in breast cancer

This publication has 26 references indexed in Scilit:

• DNA repair pathways as targets for cancer therapy
  Nature Reviews Cancer, 2008
• MGMT hypermethylation: A prognostic foe, a predictive friend
  DNA Repair, 2007
• MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents
  DNA Repair, 2007
• Epidemiology of basal-like breast cancer
  Breast Cancer Research and Treatment, 2007
• Targeted Modulation of MGMT: Clinical Implications
  Clinical Cancer Research, 2006
• MGMT: its role in cancer aetiology and cancer therapeutics
  Nature Reviews Cancer, 2004
• Expression and Prognostic Significance ofO 6-Methylguanine-DNA Methyltransferase in Hepatocellular, Gastric, and Breast Cancers
  Annals of Surgical Oncology, 2001
• Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast Cancer
  Laboratory Investigation, 2001
• Methylation of selected CpGs in the humanO6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing
  Molecular Carcinogenesis, 1999
• Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors.
  Proceedings of the National Academy of Sciences, 1996